LactaLogics develops human milk-based nutrition using proprietary Gentle-UHT™ processing technology to expand access to donated breast milk. The company is led by CEO Glenn Snow and operates a 71,000-square-foot facility in Port St. Lucie, Florida. It intends to use the new financing to implement its human milk processing technology at that facility. LactaLogics combines large-scale manufacturing with donor care to ensure a reliable supply of critical nutrition for at-risk infants. Management says the effort will allow infants to access human milk from premature birth until mothers can meet breastfeeding goals. The company emphasizes expanding access and empowering mothers with surplus breast milk to safely support infants in need.

Total raised

$92M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2024